In Vitro Diagnostics Ivd Market, By Product, By Test Type, By Application, By End User, By Geography

Description

In-vitro diagnostics market is estimated to be valued at USD 118.98 Bn in 2024 and is expected to reach USD 182.82 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 6.3% from 2024 to 2031.

Report Coverage		Report Details
Base Year:	2023	Market Size in 2023/2024:	US$ 118.98 Bn
Historical Data for:	2019 to 2023	Forecast Period:	2024 to 2031
Forecast Period 2023/2024 to 2030/2031 CAGR:	6.30%	2030/2031 Value Projection:	US$ 182.82 Bn

In Vitro Diagnostics Ivd Market Share (%), By Region, 2024

Global in-vitro diagnostics market involves the testing of biological samples such as blood, urine, tissues, and others for detection of diseases. IVD technologies allow early detection of diseases which helps in timely clinical intervention and improved patient outcomes. The market growth is driven by rising geriatric population, increasing prevalence of chronic and infectious diseases, technological advancements leading to development of more accurate point-of-care and molecular diagnostic tests. However, stringent regulations for new product approvals and unfavorable healthcare reforms in some countries hinders the market growth.

Market Dynamics:

Global in-vitro diagnostics market growth is driven by rising geriatric population who are more prone to chronic diseases, increasing incidence of lifestyle diseases such as cancer and diabetes, and growing awareness regarding early disease detection. Technological advancements have led to the development of miniaturized and portable diagnostic platforms for point-of-care and home-based testing, which is another major growth driver. However, stringent regulatory guidelines for approval of new diagnostic products and reduced healthcare coverage in some regions pose threat to the market growth. Furthermore, reimbursement policies for advanced molecular diagnostic tests vary across countries which restrains the market growth. Growing healthcare expenditure in emerging nations offers lucrative opportunities.

Key Features of the Study:

This report provides in-depth analysis of the global in-vitro diagnostics market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year.
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global in-vitro diagnostics market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study includes Siemens Healthineers, Sysmex Corporation, Bio-Rad Laboratories, bioMerieux S.A., Becton Dickinson and Company, Danaher Corporation, Abbott Laboratories, F. Hoffmann-la Roche Ltd, QIAGEN N.V., Arkray Inc., Nittobo Medical Co. , Medical & Biological Laboratories Co. Ltd., Miraca Holdings Inc., Mizuho Medy Co. Ltd., Thermo Fischer Scientific Inc, Diasorin, Agilent Technologies, Inc, and Grifols SA.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
Global in-vitro diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global in-vitro diagnostics market.

Market Segmentation

Product Type:
- Reagents & Kits
- Instruments
Test Type:
- Clinical Chemistry
- Immunoassay
- Hematology
- Molecular Diagnostics
- Microbiology
- Coagulation & Hemostasis Urinalysis
- Others
Application:
- Infectious Diseases
- Diabetes
- Oncology
- Cardiology
- Nephrology
- Autoimmune Disorders
- Others
End User:
- Hospitals & Clinics
- Diagnostic Laboratories
- Academic & Research Institutes
- Others
Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles:
- Siemens Healthineers
- Sysmex Corporation
- Bio-Rad Laboratories
- bioMerieux S.A.
- Becton Dickinson and Company
- Danaher Corporation
- Abbott Laboratories
- Hoffmann-la Roche Ltd
- QIAGEN N.V.
- Arkray Inc.
- Nittobo Medical Co.
- Medical & Biological Laboratories Co.
- Miraca Holdings Inc.
- Mizuho Medy Co. Ltd.
- Thermo Fischer Scientific Inc
- Diasorin
- Agilent Technologies, Inc
- Grifols SA

Product Code: CMI195

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Product
- Market Snapshot, By Test Type
- Market Snapshot, By Application
- Market Snapshot, By End User
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Market Trends
Recent Developments
Acquisitions and Partnerships Scenario
Technology Overview
PEST Analysis

4. Global In-Vitro Diagnostics Market- Impact of Coronavirus (COVID-19) Pandemic

Overall Impact
Impact on Supply and Demand
COVID-19 Impact on the market

5. Global In-Vitro Diagnostics Market, By Product, 2019 - 2031, (US$ Billion)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Reagents & Kits
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Billion)
Instruments
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Billion)

6. Global In-Vitro Diagnostics Market, By Test Type, 2019 - 2031, (US$ Billion)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Clinical Chemistry
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Billion)
Immunoassay
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Billion)
Hematology
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Billion)
Molecular Diagnostics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Billion)
Microbiology
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Billion)
Coagulation
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Billion)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Billion)

7. Global In-Vitro Diagnostics Market, By Application, 2019 - 2031, (US$ Billion)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Infectious Diseases
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Billion)
Diabetes
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Billion)
Oncology
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Billion)
Cardiology
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Billion)
Nephrology
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Billion)
Autoimmune Disorders
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Billion)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Billion)

8. Global In-Vitro Diagnostics Market, By End User, 2019 - 2031, (US$ Billion)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Hospitals & Clinics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Billion)
Diagnostic Laboratories
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Billion)
Academic & Research Institutes
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Billion)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Billion)

9. Global In-Vitro Diagnostics Market, By Region, 2019 - 2031, (US$ Billion)

Introduction
- Market Share Analysis, By Region, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, For Region, 2019-2031
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (US$ Billion)
U.S.
Canada
Latin America
Brazil
Mexico
Argentina
Rest of Latin America
Europe
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Middle East
GCC
Israel
Rest of Middle East
Africa
North Africa
Central Africa
South Africa

10. Competitive Landscape

Siemens Healthineers
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Sysmex Corporation
Bio-Rad Laboratories
bioMerieux S.A.
Becton Dickinson, and Company
Danaher Corporation
Abbott Laboratories
F. Hoffmann-la Roche Ltd
QIAGEN N.V.
Arkray, Inc.
Nittobo Medical Co., Ltd.
Medical & Biological Laboratories Co., Ltd.
Miraca Holdings Inc.
Mizuho Medy Co., Ltd.
Thermo Fischer Scientific Inc
Diasorin
Agilent Technologies, Inc
Grifols SA

11. Analyst View

Wheel of Fortune
Analyst View
Coherent Opportunity Map

12. References and Research Methodology

References
Research Methodology
About us and Sales Contact